Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001352414-10-000006

Chief Financial Officer acquired 8,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Evans James S · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2010-05-07 Exercise or conversion : show line 1 in the form +8,750 $4.44 $38,850 43,041 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-05-07 Exercise or conversion : show line 2 in the form Incentive Stock Option (right to buy) −8,750 $4.44 2013-09-09 8,750 0 D
Loading xslF345X03/edgardoc.xml…